THE BEST SIDE OF FENTANYL CLEARANCE

Coadministration of pexidartinib (a CYP3A4 inducer) with sensitive CYP3A substrates might bring about serious therapeutic failures. If concomitant use is unavoidable, boost the CYP3A substrate dosage in accordance with permitted products labeling.viloxazine will increase the level or effect of fentanyl by affecting hepatic/intestinal enzyme CYP3A4